Finance

Lists
AHCO:NASDAQ
Adapthealth Corp
USD 6,06
-0,08%
(-0,0050) 1D
USD 6,06
0,00% (0,00)
After hours
Closed: 9 Okt., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AHCO...
Open
USD 6,10
High
USD 6,10
Low
USD 5,96
Mkt. cap
825,56 m
Avg. vol.
2,67 m
Volume
1,46 m
52-wk high
USD 13,43
52-wk low
USD 5,21
EPS
-USD 1,68
Beta
1,42
Shares outstanding
136,34 m
No. of employees
11 k
Open
USD 6,10
High
USD 6,10
Low
USD 5,96
Mkt. cap
825,56 m
Avg. vol.
2,67 m
Volume
1,46 m
52-wk high
USD 13,43
52-wk low
USD 5,21
EPS
-USD 1,68
Beta
1,42
Shares outstanding
136,34 m
No. of employees
11 k
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
1 dag gelede
Understanding Momentum Shifts in (AHCO)
About Adapthealth Corp
CEO-
Employees10,9 k
Founded2012
HeadquartersConshohocken, Pennsilvanië, Verenigde State van Amerika
SectorHealth care provider
Websiteadapthealth.com
Analyst ratings
Based on 6 analysts giving stock ratings to AHCO in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for AHCO in the last 3 months.
Highest
Current USD 6,06
USD 10,00 (+65,02%)
Average
USD 9,40 (+55,12%)
Lowest
USD 8,00 (+32,01%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eric Coldwell
Robert W. Baird
Buy
Maintained
USD 9,00
+48,5%
09/17/2026
Brian Tanquilut
Jefferies
Buy
Maintained
USD 10,00
+65%
09/15/2026
David S Macdonald
Truist Financial
Buy
Maintained
-
-
09/09/2026
Richard Close
Canaccord Genuity
Buy
Maintained
USD 10,00
+65%
09/09/2026
Kevin Caliendo
UBS
Buy
Reiterated
USD 10,00
+65%
08/24/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
USD 8,00
+32%
08/05/2026
Jack Slevin
Jefferies
Buy
Upgraded
USD 13,00
+114,5%
07/21/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
USD 9,50
+56,8%
02/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
820,31 m
846,29 m
679,87 m
740,31 m
Cost of goods sold
639,98 m
661,38 m
563,34 m
611,86 m
Cost of revenue
639,98 m
661,38 m
563,34 m
611,86 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
103,10 m
122,54 m
114,78 m
114,26 m
Operating expense
113,20 m
132,47 m
121,95 m
122,21 m
Total operating expenses
753,18 m
793,85 m
685,29 m
734,07 m
Operating income
67,13 m
52,44 m
-5,42 m
6,24 m
Other non operating income
-
726,00 k
-
-
EBT including unusual items
36,35 m
-97,99 m
-31,02 m
-165,33 m
EBT excluding unusual items
41,75 m
28,72 m
-31,02 m
-19,97 m
Income tax expense
10,60 m
3,54 m
-7,16 m
-21,23 m
Effective tax rate
29,16%
-3,62%
23,10%
12,84%
Other operating expenses
-
-
-
-
Net income
24,51 m
-102,77 m
-16,04 m
-133,93 m
Net profit margin
2,99%
-12,14%
-2,36%
-18,09%
Earnings per share
0,23
0,27
-0,05
-0,07
Interest and investment income
-
-
-
-
Interest expense
-25,38 m
-24,44 m
-25,59 m
-26,21 m
Net interest expenses
-25,38 m
-24,44 m
-25,59 m
-26,21 m
Depreciation and amortization charges
10,10 m
9,93 m
7,17 m
7,95 m
EBITDA
157,75 m
149,94 m
106,09 m
131,57 m
Gain or loss from assets sale
-
-377,00 k
-
-6,27 m
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme